[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…
Tag: Pharmaceuticals
FDA approves new blood test to screen for colon cancer
[ad_1] The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to…
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
[ad_1] The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on…
European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai
[ad_1] European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating…
Novo Nordisk’s Wegovy wins EU backing for reducing heart risks
[ad_1] Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie…
Viking Therapeutics stock jumps nearly 30% after drugmaker moves weight loss injection to late-stage trial
[ad_1] Weight loss drug concept. Cr | Istock | Getty Images Shares of Viking Therapeutics jumped…
Pfizer’s gene therapy for rare genetic bleeding disorder succeeds in late-stage trial
[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said its experimental gene…
Novo Nordisk’s Wegovy weight loss drug wins UK approval for use as a heart treatment
[ad_1] Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto |…
Pfizer moves forward with once-daily version of weight loss pill after setbacks
[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward…
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
[ad_1] A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain,…
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
[ad_1] A sign with the company logo sits outside of the headquarters campus of Eli Lilly…
FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter —…